Tag: phase 1 study

September 30, 2019

Cue Biopharma Begins Patient Dosing in Phase 1 Study

The company's Phase 1 study aims to treat patients with PHV16-driven recurrent/metastatic head and neck squamous cell carcinoma.
September 19, 2019

PDS Biotechnology Reports Clinical Data for Novel Immunotherapy PDS101

According to the company, 60 percent of evaluable patients exhibited a clinical response in the study. Activity was observed at...
August 20, 2019

Mersana Therapeutics Expands Study of XMT-1536

Mersana Therapeutics (NASDAQ:MRSN) has announced it has dosed the first patient in its Phase 1 study of XMT-1536 in patients...
August 31, 2018

Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study

Altimmune (Nasdaq:ALT) a clinical-stage immunotherapeutics company, today announced initial data from its Phase 1 study of NasoShield under investigation as...
May 9, 2018

Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update

Prothena (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and orphan...
April 16, 2018

NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients

NewLink Genetics (NASDAQ:NLNK), today reported initial data from NLG2105, a Phase 1 study evaluating indoximod, its IDO pathway inhibitor, in combination with radiation and...
April 10, 2018

Wave Life Sciences and Deep Genomics Form Collaboration, Share Prices Increase

In the midst of a quiet time for the biotech industry, partnerships remain consistent and are keeping investors interested in...